Compare BLDR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | RGEN |
|---|---|---|
| Founded | 1998 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.6B |
| IPO Year | 2005 | 1995 |
| Metric | BLDR | RGEN |
|---|---|---|
| Price | $85.36 | $137.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $121.76 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $15,190,638,000.00 | $141,236,000.00 |
| Revenue This Year | $0.71 | $14.30 |
| Revenue Next Year | $4.52 | $14.52 |
| P/E Ratio | ★ N/A | $927.07 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $65.10 | $100.99 |
| 52 Week High | $151.03 | $175.77 |
| Indicator | BLDR | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 58.18 |
| Support Level | $74.63 | $130.40 |
| Resistance Level | $94.97 | $141.46 |
| Average True Range (ATR) | 4.25 | 6.38 |
| MACD | 1.21 | 0.36 |
| Stochastic Oscillator | 68.47 | 52.28 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.